Robert Douglas Bruce MD, MA, MSc
Associate Clinical Professor of Medicine (Infectious Diseases)
Substance abuse/dependence; Infectious diseases; HIV; Hepatitis C
Current ProjectsDr. Bruce’s project, Integrating Hepatitis C Treatment within Methadone Maintenance Programs aims to develop and implement HCV treatment in a substance abuse treatment site. Specifically, to examine the feasibility of integrating HCV treatment into existing models of methadone maintenance therapy and will consist of two phases, the first which establish the feasibility of integrating HCV treatment into existing models of methadone maintenance therapy (MMT) and once feasibility has been established, the second phase will conduct a pilot study of one model of delivering HCV treatment. The model will compare co-location of MMT with HCV treatment and MMT with offsite HCV treatment.
Dr. Bruce's scholarly work focuses on the intersection of substance abuse/dependence and infectious diseases, particularly HIV and Hepatitis C. Dr. Bruce is the recipient of a NIDA Career Development Award to improve health outcomes among drug users at the intersection of infectious diseases (especially HIV and HCV) and addiction. There are several specific sub-themes that are embedded in that overall focus and they are: 1) integration efforts to improve health outcomes; 2) pharmacokinetic interaction studies between HIV/HCV/TB treatments and treatments for substance dependence (e.g., buprenorphine/methadone); 3) ethical issues regarding the conduct of research and the provision of clinical care at the intersection of infectious diseases and addiction.